Under the shadow of aggressive trade policies from Trump, Johnson & Johnson is testing the Ottava system.
1 report, 1 independent
Updated Aug 25
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Under the shadow of aggressive trade policies from Trump, Johnson & Johnson is testing the Ottava system.
Who's involved
What this event is mainly aboutKeep exploring
Part of
Johnson & Johnson, Medtronic plc, and Omega Healthcare are noted as major medical device makers and dividend-paying healthcare stocks.Also in this story
- Johnson & Johnson and Medtronic are noted as good dividend stocks while also dealing with a huge class-action lawsuit.
- BDX, Medtronic plc, and Universal Health Services are discussed as dividend-paying stocks.
The entities involved
-
Johnson & Johnson
U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer
Coverage
Newest first; wire copies grouped- Motley FoolShould You Buy Intuitive Surgical Stock Today, or Wait for a Better Price? Intuitive Surgical's underlying business looks strong. It may face increased competition, tariff-related impacts, and valuat